Author Correction: Relieving ER stress to target NASH-driven hepatocellular carcinoma

Saskia Reibe; Mark A Febbraio

doi:10.1038/s41574-019-0154-1

Author Correction: Relieving ER stress to target NASH-driven hepatocellular carcinoma

Nat Rev Endocrinol. 2019 Feb;15(2):126. doi: 10.1038/s41574-019-0154-1.

Authors

Saskia Reibe¹, Mark A Febbraio^{2

3}

Affiliations

¹ Division of Diabetes & Metabolism, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
² Division of Diabetes & Metabolism, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. m.febbraio@garvan.org.au.
³ Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia. m.febbraio@garvan.org.au.

PMID: 30610220
DOI: 10.1038/s41574-019-0154-1

Abstract

In the original version of this manuscript, the incorrect names for two proteins were given. S1P and S2P should have been defined as site-1 protease and site-2 protease. This has been corrected in the HTML and PDF versions of the manuscript.

Publication types

Published Erratum